IRIS
CONTE, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 719
NA - Nord America 316
EU - Europa 251
SA - Sud America 84
AF - Africa 83
OC - Oceania 1
Totale 1.454
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 383
US - Stati Uniti d'America 289
HK - Hong Kong 155
RU - Federazione Russa 82
BJ - Benin 59
BR - Brasile 58
CN - Cina 53
IT - Italia 52
VN - Vietnam 47
KR - Corea 38
DE - Germania 35
AT - Austria 22
CA - Canada 19
ZA - Sudafrica 14
AR - Argentina 12
PL - Polonia 12
UA - Ucraina 12
FI - Finlandia 10
GB - Regno Unito 8
IN - India 8
BD - Bangladesh 7
JP - Giappone 6
ES - Italia 5
VE - Venezuela 5
EC - Ecuador 4
IQ - Iraq 4
NL - Olanda 4
JM - Giamaica 3
MX - Messico 3
PY - Paraguay 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EG - Egitto 1
FR - Francia 1
GM - Gambi 1
JO - Giordania 1
MW - Malawi 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 1.454
Salva come PNG Salva come JPEG
Città #
Hong Kong 155
Singapore 153
Ashburn 62
Cotonou 59
Seoul 38
Los Angeles 32
Beijing 29
Buffalo 25
Moscow 25
Ho Chi Minh City 21
Assago 20
Nuremberg 12
New York 11
Helsinki 10
Vienna 10
Hanoi 9
Munich 9
Redondo Beach 9
Dallas 8
Johannesburg 8
Warsaw 8
São Paulo 6
Boston 5
Brembate di Sopra 5
Chennai 5
Milan 5
Montreal 5
Novara 5
Tokyo 5
Toronto 5
Atlanta 4
Chicago 4
Brooklyn 3
Caracas 3
Da Nang 3
Denver 3
Falkenstein 3
Hải Dương 3
Kingston 3
Ottawa 3
Poplar 3
San Francisco 3
Santa Clara 3
Stockholm 3
Tianjin 3
Amsterdam 2
Asunción 2
Baghdad 2
Baie-D'Urfé 2
Bishkek 2
Buenos Aires 2
Camaiore 2
Carapicuíba 2
Curitiba 2
Frankfurt am Main 2
Guarulhos 2
Haiphong 2
Houston 2
Katowice 2
Manchester 2
Marcos Paz 2
Matino 2
Mumbai 2
Nairobi 2
Parauapebas 2
Phoenix 2
Phủ Lý 2
Quito 2
Rio de Janeiro 2
Sarno 2
Secaucus 2
Venice 2
Abidjan 1
Abuja 1
Americana 1
Amman 1
Ananindeua 1
Andradas 1
Barcelona 1
Bariloche 1
Barra Bonita 1
Barra da Estiva 1
Barras 1
Bauru 1
Belo Horizonte 1
Benito Juarez 1
Bismarck 1
Boca Toma 1
Boulder 1
Cairo 1
Calgary 1
Candeias 1
Canoinhas 1
Cape Town 1
Cariacica 1
Changsha 1
Charlotte 1
Cleveland 1
Cosmópolis 1
Cotia 1
Totale 888
Salva come PNG Salva come JPEG
Nome #
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy 55
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence 53
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 52
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 51
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 51
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial 49
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 47
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer 45
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer 44
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis 43
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 41
Frequency and spectrum of PIK3CA somatic mutations in breast cancer 40
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy 40
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients 40
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 39
Update on the management of breast cancer during pregnancy 38
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer 37
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 36
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy 36
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis 36
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients 33
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate 33
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 32
Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report. 32
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 31
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies 31
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 29
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 29
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 29
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 28
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 26
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 26
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 25
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 24
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 24
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer 23
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 23
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 22
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis 22
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 20
Luteinizing hormone-releasing hormone analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor-positive breast cancer 20
Management of young women with early breast cancer 20
Management of young women with early breast cancer 20
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer 18
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 15
null 6
null 5
null 4
null 4
null 2
Totale 1.529
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025733 0 0 0 87 28 90 63 62 171 82 25 125
2025/2026796 108 73 151 126 284 54 0 0 0 0 0 0
Totale 1.529